Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Jon9800

V.HEM

The participation of Officer in the offering by TSX-V

The participation of an Officer in the offering constitutes a related...

June 22, 2022

V.HEM

Hemostemix informs regarding non-brokered private placement

Hemostemix Inc. announces a non-brokered private placement of up to 15...

June 21, 2022

V.HEM

Hemostemix Inc. interest payment on convertible debenture

Hemostemix Inc. announced that it will pay interest of $84,804.40 by...

June 21, 2022

V.HEM

$HMTXF grants the worldwide field use license to PreCerv Inc

Hemostemix recently granted the global field license of use of NCP-01 and its...

June 21, 2022

V.HEM

$HMTXF to issue the global field use license of NCP-01 to Pr

Hemostemix will grant PreCerv a global field of use licence for NCP-01 and...

June 21, 2022

V.HEM

Data audit productively performed, results came out to be au

Hemostemix have been handed back its intellectual property consisting of all...

June 20, 2022

V.HEM

$HEM outstanding shares and public float idea

$HMTXF has successfully offered and issued an aggregate of 68.2 Million to...

June 20, 2022

V.HEM

$HEM could benefit enormously by the addition of Rick Groome

Mr. Rick Groome, a financial advisor, was recently inducted to the Hemostemix...

June 20, 2022

V.HEM

$HEM – TSX-V Insights

Hemostemix operates as a biotechnology-based company focusing on developing...

June 17, 2022

V.HEM

$HMTXF grants global field license to PreCerv Inc.

Hemostemix recently granted the global field license of use of NCP-01 and its...

June 17, 2022

V.HEM

$HMTXF sent-off investors flabbergasted with the recent run

  HMTXF today marked a rather gallant opening on the OTC market, and is...

June 17, 2022

V.HEM

ACP-01 ample efficiency in curing cardiac diseases

ACP-01 (Angiogenic cell precursors) is on track its 2’nd phase clinical trial...

June 16, 2022

V.HEM

Hemostemix has a 15 million market capitalization.

Hemostemix Inc. (OTCQB: HMTXF) is a clinical-stage biotechnology company with...

June 16, 2022

V.HEM

Hemostemix Inc. Market Graph

Hemostemix Inc. holds a significant role in TSX-V with its greater difference...

June 15, 2022

V.HEM

Hemostemix Inc. Stock overview

Hemostemix is a Canadian based biotechnology company listed on TSX-V...

June 15, 2022

V.HEM

Hemostemix information regarding intellectual property

Hemostemix Inc. recently announced the settlement of all litigation with...

June 15, 2022

V.HEM

The Exercise Price option granted by $HEM

According to Hemostemix Inc., all the stock options were granted with an...

June 15, 2022

V.HEM

The Peer review Articles by Hemostemix

The company has published seven peer reviewed articles about the safety and...

June 15, 2022

V.HEM

$HMTXF’s new operations vice president with an spotless resu

Mr. Pete Palvin who recently joined as vice president to the operations...

June 14, 2022

V.HEM

$HMTXF reports private placement of 15 million units Hemost

Hemostemix in a recent press release has announced a non-brokered private...

June 14, 2022

Prev 1 2 3 4 5 Next

Featured Company

Visionstate Corp.

Visionstate Corp. V.VIS

Visionstate Corp. is a growth-oriented company that invests in the research and development of the Internet of Things, big ... view more »